Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · Maryland
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Baltimore (570,000 residents, 2,840,000 metro). Johns Hopkins is the flagship academic institution; Maryland Medicaid covers T2D GLP-1s with prior auth.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Baltimore →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Baltimore →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Baltimore →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Baltimore →
Baltimore is a south-region city with a population of 570,000 (2,840,000 in the broader metropolitan area). Maryland expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Johns Hopkins Medicine, University of Maryland Medical System.
Maryland's Medicaid program is Maryland Medicaid (HealthChoice). Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.